Two receptor tyrosine kinases, ErB-3 and ErbB-4, mediate signaling by Neu dierentiation factors (NDFs, also called neuregulins), while ErbB-1 and ErbB-2 serve as co-receptors. We show that the two NDF/neuregulin receptors dier in spatial and temporal expression patterns: The kinase-defective receptor, ErbB-3, is expressed primarily in epithelial layers of various organs, in the peripheral nervous system, and in adult brain, whereas ErbB-4 is restricted to the developing central nervous system and to the embryonic heart. An example of alternating expression of the two receptors is provided by the developing cerebellum: During postnatal cerebellar development, ErbB-4 expression slightly decreases along with a decline in NDF transcription, whereas ErbB-3 expression commences after the peak of neurogenesis. To study functional dierences, we established primary brain cultures and found that ErbB-3 was expressed only in oligodendrocytes, whereas ErbB-4 expression was shared by oligodendrocytes, astrocytes and neurons. Blocking the action of endogenous NDF in vitro, by using a soluble form of ErbB-4, accelerated neurite outgrowth in both primary cultures and in neuronal-type cultures of the P19 teratocarcinoma, suggesting an inhibitory eect of NDF on neural dierentiation. Apparently, ErbB-3 is associated with proliferation of P19 cells, whereas ErbB-4 correlates with a dierentiated phenotype. We conclude that the two NDF receptors play distinct, rather than redundant, developmental and physiological roles.
Introduction
The NDF/neuregulin family includes more than a dozen growth and dierentiation factors that share an epidermal growth factor-(EGF-) like motif, serving as the receptor binding domain Carraway and Burden, 1995) . Various neuregulin isoforms were discovered by dierent bioassays that re¯ect the multiple physiological functions of this polypeptide factor family. Thus, the ability of NDFs to stimulate tyrosine phosphorylation of a breast tumor protein, ErbB-2, and control dierentiation or proliferation of mammary cells, led to the isolation of the Neu dierentiation factor (NDF) Wen et al., 1992) and heregulin (Holmes et al., 1992) .
A strong mitogenic activity on Schwann cells enabled isolation of the glial growth factors (GGFs) (Marchionni et al., 1993) , whereas the ability of another neuregulin isoform to elevate expression of the nicotinic acetylcholine receptor in muscle cells was utilized in isolating ARIA (Falls et al., 1993) . The availability of recombinant forms of NDF/neuregulin opened the way for more detailed in vitro and in vivo studies, collectively characterizing two major groups of biological roles for NDFs/neuregulins. First, the factors appear to act as potent inducers of epithelial morphogenesis and dierentiation. An example is provided by the mammary gland, where NDF acts as as inducer of dierentiation in vitro (Bacus et al., 1993) and aects lobulo-alveolar budding and milk production in isolated glands (Yang et al., 1995) . Likewise, dierent isoforms of NDF can extend cell survival or act as potent mitogens for cultured keratinocytes (Marikovsky et al., 1995) , while a speci®c isoform mediates directional migration and epidermal differentiation during cutaneous wound repair in vivo (Danilenko et al., 1995) .
Apart from their action as short-range paracrine mediators of mesenchyme-epithel inductive processes (Pinkas-Kramarski et al., 1997) , NDFs play a pivotal role in the nervous system, primarily in communicating nerve cells to non-neuronal cells. Neuregulins act as the most potent mitogens for precursor Schwann cells in vitro (Dong et al., 1995) , and they reduce apoptosis of mature Schwann cells upon axotomy (Grinspan et al., 1996) , probably re¯ecting a role in attaining the appropriate ratio of neurons to Schwann cells in adults (Syroid et al., 1996) . An in vivo eect on synaptic Schwann cell survival after denervation has been recently demonstrated (Trachtenberg and Thompson, 1996) . Myelin-forming cells of the central nervous system, the oligodendrocytes, are also targets of NDFs/ neuregulins (Vartanian et al., 1994; Canoll et al., 1996) , as are embryonic astroglia, whose maturation and survival are aected, but not their proliferation (Pinkas-Kramarski et al., 1994 ). An instructive signal of neuregulin for glial dierentiation, on the expense of a neuronal fate, was demonstrated by using neural crest stem cells (Shah et al., 1994) .
Part of the physiological complexity of the NDF/ neuregulin family may be explained by its unique combinatorial signaling. Two distinct receptor tyrosine kinases, ErbB-3 and ErbB-4, mediate NDF actions by acting as a low and a high anity receptor, respectively (Tzahar et al., 1994) . Two other members of the ErbB family, ErbB-1 (also called EGF-receptor) and ErbB-2, function as co-receptors, whose recruitment into . Inter-receptor interactions generate a complex network that enables diversification and more stringent control of NDF signaling (Riese et al., 1995; Pinkas-Kramarski et al., 1996) . In addition to their dierential heterodimeric preferences, the two NDF receptors dier in their selection of cytoplasmic signaling proteins containing Src homology 2 (SH2) domains . However, the most signi®cant dierence is the catalytic tyrosine kinase function, which is practically inactive in ErbB-3, but intact in ErbB-4 (Guy et al., 1994) . Therefore, homodimers of ErbB-3 are biologically inactive but their function may be reconstituted by a co-expressed ErbB-1 or ErbB-2 (Riese et al., 1995; Pinkas-Kramarski et al., 1996) . ErbB-2, the most oncogenic member of the family, has no known ligand, but by decelerating ligand dissociation, it functions as a shared signaling subunit of all direct receptors (Graus-Porta et al., 1995; Karunagaran et al., 1996) . Gene targeting experiments supported this notion and added more functions to the list of neuregulin roles: ErbB-2-de®cient mice (Lee et al., 1995) shared a similar phenotype with both NDF/ neuregulin-knockout animals Kramer et al., 1996) , and with ErbB-4-defective mice (Gassmann et al., 1995) , in that formation of the heart trabeculae was impaired, causing embryonic lethality. In addition, NDF-and ErbB-2-de®cient mice showed similar alterations in the developing nervous system; the cranial ganglia did not develop normally. In addition, NDF mutants lacked Schwann cell precursors along peripheral projections from the spinal cord , and ErbB-4-de®cient mice displayed no loss of cells of the cranial sensory ganglia, but existing axons miss-innervated the hind brain (Gassmann et al., 1995) .
Because they act as distinct components of a signaling network, ErbB-3 and ErbB-4 may dier not only in their structure and biochemical function, but also in their spatial and temporal expression patterns. The present study explored this possibility, and also addressed the eect of neuregulins on neurons. Although this cell type often expresses neuregulins and their receptors (Meyer and Birchmeier, 1994; Pinkas-Kramarski et al., 1994; Corfas et al., 1995) , and the neuron-derived ligand acts on many types of non-neuronal cells, the eect of NDF on nerve cells has not been extensively investigated before. Here we show that the patterns of expression of the two NDF receptors are remarkably dierent: The embryonic central nervous system and heart being primary sites of ErbB-4 expression, whereas the epithelial component of various parenchymal organs and the adult nervous systems are the main locations of ErbB-3. In vitro studies with primary and established culture systems demonstrated the dynamic nature of NDF receptor expression, and indicated that the shared NDF ligand can restrict neuronal dierentiation.
Results

Dierential expression of NDF receptors in mouse development
NDF, the ligand of ErbB-3 and ErbB-4, is predominantly expressed in the central and peripheral nervous systems, but it is also expressed in other organs, such as the adrenal gland, liver and intestine (Marchionni et al., 1993; Orr-Urtreger et al., 1993; Chen et al., 1994; Birchmeier, 1994, 1995; Pinkas-Kramarski et al., 1994; Corfas et al., 1995; Ho et al., 1995) . It has been previously shown by using Northern blot analysis, that the two NDF receptors are widely expressed in various epithelial cell lines (Prigent et al., 1992; Plowman et al., 1993) . In addition, in situ hybridization detected erbB-3 transcripts in Schwann cell precursors and in cranial ganglia cells , whereas erbB-4 transcripts were detected in the heart, brain and embryonic hindbrain (Lai and Lemke, 1991; Gassmann et al., 1995) .
In an attempt to extend these studies, and to compare the expression patterns of the two NDF receptors, we cloned the ectodomain-coding portions of the rat erbB-3 and erbB-4, by using PCR and the appropriate cDNAs (see Materials and methods). These were used as probes on cryotome sections of E14.5 mouse embryos, a developmental stage representing a post-organogenesis phase. Comparison of sagittal sections, that were probed with antisense RNAs revealed remarkably dierent patterns of embryonic erbB-3 and erbB-4 expression ( Figure 1 ): Whereas erbB-3 was expressed predominantly in the trunk, erbB-4 signals were concentrated in the heart, head and spinal cord. Speci®cally, identi®ed sites of erbB-3 expression at this stage of development were the epithelial component of most body organs (e.g., skin, olfactory and respiratory epithalia, stomach, intestine, liver and kidney), muscles (e.g., tongue and skeletal muscles), and vertebrate column. However, erbB-4 expression was restricted to most parts of the developing central nervous system, including cerebral cortex, thalamus, pons and medulla, cerebellum, and the spinal cord. In addition, erbB-4 was expressed in heart myocardium.
Higher magni®cation analysis of the in situ hybridization results con®rmed localization of erbB-3 transcripts to the epithelial layer of parenchymal organs, such as stomach, intestine and lungs ( Figure  1 , lower part), in close proximity to the neuregulin/ NDF-expressing layer of stromal cells (Orr-Urtreger et al., 1993) . For example, the columnar epithelial lining of the lung terminal bronchioles is rich in erbB-3 transcripts, but the surrounding mesenchyme displays only limited punctuate labeling. By contrast, in the luminal epithelia of all these organs, erbB-4 was hardly detectable. On the other hand, in certain brain areas, expression of the Erb-4 transcript was exclusive. Examples include the erbB-4 expressing forebrain, pons and medulla, and subventricular zone (lateral ventricle), another region where NDF/neuregulin is highly expressed at mid-gestation (Orr-Urtreger et al., 1993; Meyer and Birchmeier, 1994) . These areas show almost no erbB-3 expression at mid-gestation.
Expression analyses were also performed in two additional developmental stages: E10.5 and 16.5. Coronal sections through brain and spinal cord at the later developmental stage detected erbB-4 transcripts in certain brain regions and in the dorsal and ventral gray horns of the spinal cord (Figure 2b and e). erbB-3 was present neither in brain nor in spinal cord at this developmental stage (Figure 2a and d) . The marginal region (white matter) of the spinal cord was devoid of both erbB-3 and erbB-4, but the two types of transcripts were present, albeit at relatively low levels, in the dorsal root ganglia, in the surrounding cartilage primordia of vertebral body and neural arch, as well as in nearby muscles. Remarkably, several isoforms of NDF/neuregulin were localized to the dorsal root ganglia (in both motor-and sensory neurons), and to the entire spinal cord, at this relatively late developmental stage (Marchionni et al., 1993; Orr-Urtreger et al., 1993; Ho et al., 1995) . In brain, a mostly punctuate erbB-4 labeling at E16.5 was detected in the neopallial cortex (future cerebral cortex), in both the marginal zone, mostly in the anuclear cell layer, and in the ventricular zone (Figures 1b and 2b , and data not shown). It is worth noting that dierentiation of cortical neurons starts in the sub-ventricular cell layer, and the dierentiating cells later migrate radially to their cortical destinations. Coronal and sagittal sections obtained from E10.5 embryos re¯ected no expression of erbB-3 in the central nervous system, but relatively high erbB-4 expression in the spinal cord (ventral portion) and in the myocardium, as well as in the neuroepithelium of the telecephalic vesicle (data not shown). Therefore, based upon the results of in situ hybridization, we concluded that ErbB-4 may function as the major NDF receptor in the developing central nervous system, but ErbB-3 may act at this developmental stage in many epithels, as well as in the peripheral nervous system.
Expression of NDF receptors in adult brain and in the developing cerebellum
In order to extend our analyses to adult brain, we chose to study the more extensively characterized brain of the rat. Serial sections of the brain of a 3 month-old rat indicated that, unlike in embryonic brain, both erbB-4 and erbB-3 were expressed in multiple brain regions (Figure 3 and data not shown). Shared sites of expression included the piriform cortex, olfactory bulb, Figure 1 erbB-3 and erbB-4 expression in E14.5 mouse embryos. Mid-sagittal sections of mouse embryos at day 14.5 post coitum were hybridized to 35 S-labeled antisense probes corresponding to either erbB-3 (B, E and H) or erbB-4 (C, F and I). Control sections are shown as bright ®eld images (A, D and G). The following organs are marked: forebrain (fb), hindbrain (hb), heart (ht), intestine (i), lung (lu), liver (lv), spinal cord (sc), stomach (st), mandible (mb). Speci®c organs, including stomach (st), intestine (i) and lung (lu), are shown in high magni®cation views in the lower panels. Bar lengths are 1 mm in the upper part (A ± C) and 200 m in the lower panels various cortical regions, reticular thalamic nucleus, hippocampus, substantia nigra compacta and the diagonal band. However, only erbB-4 was expressed in the supramammillary nucleus and in the ventral pallidum. An example of dierent expression patterns was provided by the cerebral cortex (Figure 3e and f): Both erbB-3 and erbB-4 transcripts were localized to cell bodies in the cortex. However, whereas erbB-4 signals were restricted to occasional cells of all cortical layers, erbB-3 was evenly distributed in all cell layers, except for the somewhat denser expression in layer VI. It is noteworthy that the adjacent layer V contains more NDF transcripts than other layers of the cerebral cortex (Chen et al., 1994) .
Similar to the expression pattern of NDF/neuregulin in adult rat brain (Chen et al., 1994; Pinkas-Kramarski et al., 1994) , both receptors were expressed in regions of the limbic and the motor systems. These include various sites in the cerebral cortex (e.g. frontal, forelimb, hindlimb, parietal, piriform, olfactory tubercle, and occipital cortex), components of the limbic system (e.g. medial septal nucleus, pre-optic nucleus, mammillary body, and the medial habenular nucleus of the thalamus and amygdala). In addition, brain areas related to the motor system, such as motor cortex, ventral pallidum, nucleus of the diagonal band, brain stem (vestibulocochlear nerve, red nucleus and pons), and the cerebellum, were also labeled by the two dierent probes. Although both receptors were expressed in the cerebellum, their distribution maps were remarkably dierent ( Figure  3d ): Intense erbB-4 labeling corresponded to the granular layer, which contains the only excitatory interneurons of the cerebellum, but no signal was localized to the molecular layer. On the other hand, erbB-3 expression was widespread, but it was denser in the Purkinje cell layer, containing the only projecting neurons of the cerebellum. Remarkably, GGF expression was detected in the granular layer of adult brain, probably in Golgi type II cells, but at earlier postnatal stages, transcripts were mapped to the combined Purkinje and molecular layer, perhaps re¯ecting cell migration from the external granular layer into the internal one (Chen et al., 1994) .
Because the cerebellum develops postnatally, it enables convenient examination of possible changes in erbB expression during development. To this end, we extracted RNA from cerebella of rats at various postnatal ages and analysed their content of transcripts coding for NDF/neuregulin and its two receptors. The results of this analysis indicated that ligand expression dramatically decreased with age, whereas a parallel increase in erbB-3 expression and a concomitant moderate down-regulation of erbB-4, occurred in the ®rst 3 weeks of postnatal life ( Figure  4 ). This observation is consistent with the lack of signi®cant erbB-3 expression in E10.5 mouse embryos (data not shown) and the results of immunohistochemical (Pinkas-Kramarski et al., 1994) , as well as in situ hybridization analyses (Chen et al., 1994) of neuregulin, whose neural expression appears to decrease, but not disappear, after birth. Possibly, ErbB-4 is the NDF receptor that mediates the major cerebellar neurogenic phase in the ®rst week of postnatal life, but ErbB-3 replaces it, at least in part, in later stages and in adult life. Interestingly, mostly a high molecular weight transcript of NDF/neuregulin was detected at all ages, but the size of the erbB-3 message displayed a slight reduction after 2 to 3 weeks of postnatal life. This phenomenon has not been described before and its signi®cance is currently unknown.
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Figure 3 Expression of erbB-3 and erbB-4 in adult rat brain. Coronal sections of adult rat brain were subjected to in situ hybridization analysis using 35 S-labeled RNA probes for erbB-3 and erbB-4. The sections were taken from four brain regions, labeled a through d, that are illustrated in the upper scheme. The lower panels (e and f) are high magni®cation views of the labeled cortex, whose neuronal layers (I through VI) are marked by arrowheads. The following abbreviations were used: BLA, anterior basolateral amyloid nucleus; CA1 and CA3 are speci®c hippocampal regions; CPu, caudate putamen; Cx, cortex; DG, dentate gyrus; GL, granular layer; LHb, lateral habenular nucleus; Mol, molecular layer; MP, posterior medial mammillary nucleus; PC, Purkinje cell layer; Pir, piriform cortex; Str, striatum; Py, pyramidal tract; Rt, reticular thalamic nucleus; SNC, substantia nigra compacta; SNR, substantia nigra; S, septum; SP, spinal trigeminal nucleus; VC, ventral cochlear nucleus; and VMH, ventral medial habenular nucleus. Bar length is 1 mm. Magni®cation (®vefold) of cortical areas shown in part A is presented in the lower panels (e and f)
Dierential expression of the two NDF receptors in primary cultures of embryonic brain
We have previously reported that NDF/neuregulin was expressed by astroglia and neurons, but not by oligodendrocytes of late gestation rat embryos (Pinkas-Kramarski et al., 1994) . To correlate this with receptor expression, we generated primary cell cultures from E17 and newborn rat brains and enriched them for either neurons, astroglia, or oligodendrocytes, by using established protocols (McCarthy and de Vellis, 1980) . Reverse transcriptase PCR analysis of total RNA extracted from the type-selected cultures, by using speci®c oligonucleotide primers and Southern blot analysis, identi®ed erbB-3 only in oligodendrocytic cultures, but erbB-4 was expressed, at this developmental stage, in all three types of brain cells ( Figure  5a ). As control, we used two mammary cancer cells, SKBR-3 cells expressing ErbB-3 in the absence of detectable ErbB-4, and T47D cells expressing all ErbB proteins . While expression of ErbB-4 in all three types of brain cells may be due to culture contamination, we note that this observation is consistent with several recent reports (Bermingham- . Expression of erbB-3 and erbB-4 (b-actin was used as control) was analysed by using reverse transcriptase PCR and speci®c oligonucleotide primers. The ampli®ed DNA was subjected to Southern blot analysis with speci®c probes. The resulting autoradiograms are shown, and the location of a 300 base pair (bp) marker is indicated.
(b) Eects of NDF and an NDF antagonist. Non-enriched primary brain cultures were ®rst established in vitro from E17 embryos, and then their medium was replaced with a serum-free de®ned medium. Separate cultures were incubated for 4 days with no added factor (CONTROL), or with one of the following proteins, as indicated: soluble forms of ErbB-4 or ErbB-2, in the form of immunoglobulin fusion proteins (denoted IgB-4 and IgB-2, respectively), each at a concentration of 4 mg/ml, or NDFb1 14 ± 246 (100 ng/ml Figure 5b , and data not shown). To examine the possibility that endogenous NDF/neuregulin was masking the eect of the exogenously added ligand, we attempted to block the neuron-and astroglia-derived factor by using a soluble form of ErbB-4, that we have previously characterized as an eective antagonist of NDF (Dong et al., 1995; Chen et al., 1996) . This recombinant protein, denoted IgB-4, is a fusion between the extracellular ligand binding portion of ErbB-4 and the Fc portion of immunoglobulin G 1 . A 4 day-long treatment of primary brain cultures with IgB-4 resulted in remarkable enhancement of neurite outgrowth, that was more prominent upon staining with antibodies to either GAP-43 or to the neuronspeci®c enolase (Figure 5b , and data not shown). As control, we used a similar fusion protein between ErbB-2 and human IgG, denoted IgB-2. Consistent with no speci®c blocking of NDF, IgB-2 exerted no eect on neuronal dierentiation in vitro (Figure 5b) . We, therefore, concluded that an endogenouslysynthesized neuregulin (Pinkas-Kramarski et al., 1994) can inhibit neuronal dierentiation, probably through binding to ErbB-4 (Figure 5a ). However, because ErbB-4 can mediate the actions of betacellulin (Riese et al., 1996) and the heparin binding EGFlike growth factor (HB-EGF) (Elenius et al., 1997) , inhibition of neuronal dierentiation by ErbB-4 ligands, other than NDF/neuregulin, cannot be excluded. Due to the cellular heterogeneity of the primary mixed cell type culture, we could not address questions related to the cellular source of NDF/ neuregulin and the identity of its functional receptor. To overcome this limitation, we tried to reconstitute the eect with a continuous cell line, the pluripotential P19 mouse teratocarcinoma cells. This euploid immortalized cell line retained an ability to differentiate not only to neurons or skeletal muscle cells, depending on the inducing agent, either retinoic acid (RA), or dimethylsulfoxide, respectively (McBurney, 1993) , but also into cardiac myocytes, when treated with 3,5,3'-triiodo-1-thyronine (T 3 ) (Rodriguez et al., 1994) . We ®rst asked whether P19 cells, like embryonic primary neurons, express NDF receptors and the ligand itself. As is evident from Figure 6a , immunoblotting of whole cell lysates detected ErbB-3, but not ErbB-4, in unstimulated P19 cells. Similar immunoblotting analysis of heparin-binding proteins secreted into the culture medium detected low levels of NDF/neuregulin expression (approximate molecular mass of 50 kilodaltons, Figure 6b ). Interestingly, retinoic acid treatment increased NDF expression, but only after long incubation with the factor (46 days, Figure 6b ). However, NDF synthesis was further enhanced upon inhibition of cell proliferation with cytosine arabinoside (AraC, Figure 6b ), an agent known to enrich P19 cultures for neuronal precursors (Bain et al., 1993) . It is, therefore, likely that this dierentiated cell type is the source of NDF/ neuregulin.
Neuronal dierentiation has been shown, in several cellular systems, to be accompanied by up-regulation of the zinc ®nger protein, Egr-1 (Lanoix et al., 1991) . Indeed, concomitant with the characteristic growth arrest, appearance of embryoid bodies, and outgrowth of neurites, RA-treated P19 cultures displayed upregulation of the transcription factor Egr-1. This was evident from an electrophoretic mobility shift assay using a GC-rich consensus DNA sequence, that binds to all members of the Egr family (Figure 6c ) (Lemaire et al., 1990) . Interestingly, induction of an Egr-like DNA binding activity preceded morphological alterations, but incubation with a relatively high concentration of NDF-b1 rapidly abolished the DNA binding activity of Egr-1. NDF itself exerted no Egr-like DNA binding activity in proliferating P19 cells (Figure 6c ). In addition, Egr-1-speci®c antibodies recognized the DNA-protein complex of P19 cells (Figure 6c , right panel), thus identifying Egr-1 as the RA-inducible transcription factor whose activity is abolished upon treatment with NDF.
In addition to Egr-1 induction, RA-induced dierentiation of P19 cells involved changes in expression of NDF receptors: ErbB-3 expression was completely abolished upon neuronal dierentiation, but this was accompanied by new expression of ErbB-4, which was absent in proliferating P19 cells ( Figure  6a ). Thus, whereas ErbB-3 was associated with proliferating cells, ErbB-4 expression correlated with the appearance of a dierentiated phenotype. Similar to primary cultures of brain cells, inhibition of P19-derived NDF/neuregulin by using IgB-4, but not IgB-2, remarkably enhanced neurite outgrowth and led to the appearance of larger embryoid bodies (Figure 7 , and data not shown). Both the number of neurites and their diameter were increased upon treatment with the antagonist of NDF (data not shown). Moreover, the dierentiation-like eect of IgB-4 was augmented by AraC. Consistently, NDF itself exerted a weak inhibitory eect on neurite outgrowth, but this response was potentiated by AraC (Figure 7) , probably due to the observed elevated synthesis or secretion of the endogenous factor by AraC-treated cultures (Figure 6b ). In conclusion, endogenous NDF/ neuregulin appears to block neuronal dierentiation in both cellular systems we used, namely; mixed-type primary cultures of embryonic brain cells and P19 teratocarcinoma cells. The inhibitory eect is probably mediated by neuron-expressed ErbB-4, and it may involve down-regulation of the transcriptional activity of Egr-1. Cultures of P19 cells were induced to dierentiate along a neural pathway by treatment with 1 mM retinoic acid (RA). Control cultures were left untreated. Whole-cell lysates were prepared from the dierentiating cultures after 6 or 8 days, as indicated, and subjected to immunoblot (IB) analysis with a rabbit antiserum to either ErbB-3 or ErbB-4 (Santa Cruz). The lower bands in the ErbB-4 blot are non-speci®cally reacting proteins. (b) NDF expression. Media conditioned by RA-treated cultures of P19 cells, or an untreated control culture (CON) were collected after 6 to 10 days of conditioning. To inhibit cellular proliferation, some cultures were treated with cytosine arabinoside (AraC, 10 mM) 1 day following cell plating. NDF/neuregulin present in the various media was ®rst adsorbed to heparin-agarose beads, resolved by gel electrophoresis, and transferred to nitrocellulose ®lters. Immunoblotting was performed by using a rabbit antiserum to NDF. (c) Egr-1 DNA binding activity. P19 cells that were induced by RA for 5 days (RA5d), or untreated cells (C), were incubated with NDF-b1 (100 ng/ml) for the indicated periods of time, or left untreated (7). Whole cell extracts were prepared and incubated with a labeled double-stranded oligonucleotide representing an Egr-1 binding site, and analysed by gel electrophoresis and autoradiography. As control, no nuclear extract was added (lane 1). To directly identify Egr-1, extracts from dierentiated cultures were incubated with an antibody to Egr-1 (Santa Cruz) (lane 9), or with a control antibody to another zinc ®nger transcription factor, Sp1 (Santa Cruz) (lane 10). A control reaction with no antibody added is shown in lane 8. Closed arrowheads mark the locations of the mobility-retarded DNA-protein complexes (the radioactive free probe was run out of the gel), whereas the open arrowhead indicates the antibody-supershifted Egr-1 complex
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IgB-4 NDF-β +AraC -AraC -AraC Figure 7 Inhibition of neurite outgrowth of P19 cells by an NDF antagonist. P19 cells were treated with RA for 4 days and the formed cell aggregates dissociated by using trypsin. Single cell suspensions were then plated on coverslips precoated with poly1-lysine. Immediately after cells adhered to the substrate, the indicated proteins (NDF at 100 ng/ml, and IgB proteins at 4 mg/ml) were added either in the absence or in the presence of AraC (10 mM). Four days later, cells were ®xed and processed for immuno¯uorescence analysis with antibodies to GAP-43. The resulting¯uorescent micrographs are presented, along with phase micrographs. Scale bar, 100 m
Discussion
Neuregulins and their receptors present a uniquely complex signaling mechanism, comprised of multiple isoforms of the ligands, two direct receptors and two co-receptors, that are coupled to multiple, and perhaps distinct, sets of SH2-containing signaling proteins. This interactive network is thought to enable versatile biological signals, which are further compounded by the presence of some membrane-bound, as well as soluble ligands, whose expression appears to be tissueselective (Chen et al., 1994; Meyer and Birchmeier, 1994) . The present study adds another dimension to this complexity, by demonstrating spatial and temporal variation in developmental expression of the two direct NDF receptors (Figures 1 and 2) , their regional and cell type-speci®c expression in adult brain (Figures 3 ±  5) , and dynamic regulation during dierentiation in vitro ( Figure 6 ). Collectively, these results imply distinct, rather than redundant functions, of ErbB-3 and ErbB-4 in embryonic development and in neural dierentiation.
Distinct expression features of the two NDF receptors
Based on the present and previous expression studies it seems safe to conclude that during prenatal development the primary site of action of ErbB-3 are epithelial cell layers and the peripheral nervous system, whereas the major sites of expression of the other NDF receptor, ErbB-4, are the central nervous system and the myocardium. At later developmental stages, ErbB-3 appears to assume a wider distribution in the central nervous system (compare Figures 2 and 3 ). An example of this developmentally-regulated expression is provided by the cerebellum, whose prenatal low expression of ErbB-3 increases after birth, while its ErbB-4 expression decreases (Figure 4) . Nevertheless, ErbB-3 and ErbB-4 are not expressed in a mutually exclusive manner. For example, both skeletal muscles (Figure 2d and e) and some epithelia (Figure 1 , lower panel) express both receptors in mid-gestation, in line with their co-expression in certain mammary, lung, and other types of epithelial cell lines Karunagaran et al., 1996) . Distinct, but partially overlapping, patterns of expression extend also to the heterogenous cell types of brain: whereas dissociated oligodendrocytes express both receptors, neurons and astrocytes appear to contain primarily ErbB-4 ( Figure  5a ). Nevertheless, our analyses of cerebella and P19 cells indicate that the identity of the NDF receptor expressed by a speci®c cell type may be a dynamic, rather than a ®xed, cellular characteristic (Figures 4  and 6a) . By shifting expression from one NDF receptor to the other, a cell can acquire a signi®cantly dierent set of signaling properties, as the two receptors dier not only in their kinase activity and substrate selectivity , but also in their anity to NDFs (Tzahar et al., 1994) , speci®city to betacellulin (Riese et al., 1996) and perhaps also to other EGF-like ligands , and they also dier in endocytic fates (Baulida et al., 1996) . The ensuing physiologic consequences are presently dicult to approach. However, it may be relevant to relate the complexity of receptor expression to the pattern of expression of the various neuregulin isoforms. These molecules may be grouped into mesenchymal isoforms, which include NDF/heregulin variants containing a glycosylation domain and a transmembrane stretch, and neuronal isoforms (e.g., GGF and SMDF), which are primarily soluble factors with no glycosylation domain . Whereas all of the neuronal isoforms contain the higher anity b type EGF-like domain (Marikovsky et al., 1995) , the lower anity a type is the more abundant mesenchymal variant (Meyer and Birchmeier, 1994; Wen et al., 1994) . Compilation of receptor expression patterns presented in this work, and previous analyses of neuregulin isoforms (Marchionni et al., 1993; Orr-Urtreger et al., 1993; Chen et al., 1994; Meyer and Birchmeier, 1994; Ho et al., 1995) , raises the interesting possibility that ErbB-3 is the major receptor for the mesenchymal factors, whereas ErbB-4 is the primary receptor of the neuronal variants. Presumably, spatial pairing of a low anity receptor (ErbB-3) with low anity ligands (a type), and co-expression of the reciprocal high anity pair, is physiologically signi®cant. For example, the common transmembrane topology of mesenchymal isoforms, which is not shared by most neuronal factors, may enhance binding and increase availability of the lower anity ligands. This proposition is supported by the apparent short range of NDF/neuregulin action in vivo, including its involvement in cardiac development (Gassmann et al., 1995; Lee et al., 1995; Meyer and Birchmeier, 1995) , contact-induced mitosis of Schwann cells by neuron-expressed neuregulins (Morrissey et al., 1995) , co-localization of neuregulin and its receptors in the neuromuscular synapse (Zhu et al., 1995) , and mesenchyme-epithelia interaction during mammary gland development (Yang et al., 1995) .
Inhibition of neuronal dierentiation by NDF
By employing both primary cultures of brain cells and pluripotential teratocarcinoma cells, we concluded that one eect of NDF on nerve cells is inhibition of neurite outgrowth (Figures 5b, 6c and 7) . Remarkably, neuregulin inhibits dierentiation of another cell type in brain, namely the O2A bipotential progenitor of oligodendrocytes (Canoll et al., 1996) . In addition to blocking dierentiation into mature myelin basic protein-(MBP-) producing oligodendrocytes, when cultured with dierentiated cells, neuregulin caused loss of the dierentiation markers O1 and MBP (Canoll et al., 1996) . However, unlike the O2A progenitors, which are maintained by neuregulin in a proliferative state, RA-primed P19 cells do not proliferate, and blocking their proliferation with AraC even enhanced the eect of NDF withdrawal. We favor an autocrine, rather than a paracrine, mechanism of NDF action on neuronal dierentiation, because it could be demonstrated with an established cell line. However, the heterogeneity of phenotypes that can be acquired by this teratocarcinoma line excludes de®nite conclusion. A paracrine mechanism may underlie the previously reported survival and dierentiation eect on rat retinal neurons, whose number of neurite extensions, but not their size, was increased by neuregulin (Bermingham-McDonogh et al., 1996) . A reciprocal mechanism involving neuroblast-derived neuregulin, which enhances synthesis of neurotrophin 3, a factor that in turn supports neuroblast survival and dierentiation, has been demonstrated in vitro (Verdi et al., 1996) . A similar mechanism may be operational in the retinal cell system, but is unlikely in the P19 system. Therefore, the ability of an endogenous neuregulin to inhibit neurite outgrowth in primary brain cultures and in P19 cells may not contradict its dierentiation eect on retinal cells. In fact, in vitro experiments with multi-potential self-renewing neural crest cells, with characteristics of stem cells, revealed an ability of neuregulin to restrict acquisition of a neuronal lineage (Shah et al., 1994) . This observation appears in line with the inhibitory eect we observed with partially dierentiated embryonic neurons. Presumably, inhibition of neuronal dierentiation allows neuregulin to act as a lineage-determining factor on neural stem cells, but later in development this activity may instruct neurons to assume migratory characteristics or participate in plasticity-related events. An intriguing example may be provided by ErbB-4-de®cient mice (Grassmann et al., 1995) . Loss of ErbB-4 expression in rhombomeres 3 and 5 of the embryonic hindbrain caused aberrant innervation at the adjacent rhombomeres 2 and 4, by an unknown mechanism. Possibly, a barrier for axonal growth is normally maintained by neuregulin, that is expressed in rhombomers 2, 4 and 6, but loss of ErbB-4 removes this inhibition, thereby allowing mistargeting of cranial nerves.
Since induction of neuronal dierentiation of P19 cells was accompanied by disappearance of ErbB-3 and up-regulation of ErbB-4 (Figure 6a) , we conclude that ErbB-4 is associated with the dierentiated phenotype, whereas ErbB-3 is expressed by proliferating P19 cells. This alternating pattern may generalize to other cell types that respond to neuregulins. Thus, NDF/ neuregulin prevents apoptosis and accelerates maturation of astroglia, with no concomitant cell proliferation (Pinkas-Kramarski et al., 1994) , by acting on an astroglia-expressed ErbB-4 (Figure 5a ). Likewise, trabeculae formation by the heart wall is controlled by endocardial neuregulin acting on myocardial cells expressing ErbB-4 and ErbB-2 (Gassmann et al., 1995; Lee et al., 1995) . Another dierentiation-like eect of neuregulin, namely maturation of mammary cells into milk-producing cells, could be mimicked by anti-ErbB-4 antibodies , suggesting that this receptor plays a role in cell fate determination, rather than in promoting cell proliferation. Consistent with this notion, neuregulin-mediated proliferation of keratinocytes (Danilenko et al., 1995; Marikovsky et al., 1995) , mammary cells (Holmes et al., 1992) and Schwann cells correlates with coexpression of ErbB-2 together with ErB-3, rather than with ErbB-4. Thus, ErbB-3 action may be restricted to cell proliferation, in agreement with the potent mitogenic activity of this receptor in normal (PinkasKramarski et al., 1996) and in tumor cells (Alimandi et al., 1995; Wallasch et al., 1995) . However, fatedetermining processes, that do not involve mitosis, may be associated with ErbB-4, whose signaling capacity is rather limited.
In conclusion, our results add yet another dimension to the already high degree of complexity that characterizes the ErbB family: The spatial and temporal control of expression of the two NDF receptors, and their dynamic changes throughout dierentiation adds to the apparent versatility of the ErbB signaling network. The multiple ligands of these receptors appear to complement and further diversify the emerging network, by having their own isoformspeci®c expression maps (Chen et al., 1994; Meyer and Birchmeier, 1994; Wen et al., 1994) . It is interesting to note that at each site of expression, the ligands and their receptors are closely apposed, in line with shortrange interactions. In addition, shared expression appears to be restricted to two major anatomical systems, whose cellular heterogeneity is remarkably complex: the epithelial system and the nervous system. A role for neuregulins and their receptors in the generation of cellular heterogeneity of both epithelial and neural lineages is supported by genetic (Lemke, 1996) and in vitro studies (Ben-Baruch et al., 1997) , and is also implied by the absence of an ErbB network in lower organisms, such as C. elegans or Drosophila, that express only one homolog of the four mammalian ErbB proteins (Perrimon and Perkins, 1997) . Currently, it is dicult to determine whether each of the many potential signaling pathways oered by the ErbB network has a distinct physiological or developmental role.
Materials and methods
Materials and antibodies
Radioactive materials were purchased from Amersham (Buckinghamshire, UK). Recombinant NDF preparations were from Amgen (Thousand Oaks, California). Molecular weight standard proteins for sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis (PAGE) were from BioRad or from Sigma. RNAzol kit was from Cinna/Biotex Laboratories (Houston, Texas). Restriction and modification enzymes were purchased from Promega. Mouse monoclonal antisera to GAP-43 were purchased from Sigma (St. Louis, MO), and antibodies to ErbB-3 and ErbB-4 were from Santa-Cruz Biotechnology (Santa-Cruz, CA).
Embryos
C57BL/6J mice were used. The time of gestation was calculated by considering the morning after mating as day 0.5 post coitum (0.5 d.p.c.) (Hogan et al., 1986) . All embryos were pre®xed for 15 h in 4% paraformaldehyde at 48C.
In situ hybridization to mouse embryos and rat brains
To detect ErbB-3 and ErbB-4 transcripts, we have cloned the rat homologs of the two transcripts, from adult rat cerebellum, by using RT ± PCR according to a previously published protocol (Orr-Urtreger et al., 1993) . The following synthetic primers were used: erbB-3-speci®c primers: 5' -TCCTGGCCGCCCCACATGCACAAC -3' (sense oligonucleotide) and 5'-GTCACATTTGCCC-TCTGCCA-3' (antisense oligonucleotide) and erbB-4-speci®c primers: 5'-TGTGCGTGCCTGCCCTAGTTC-CAAGATGG-3' (sense oligonucleotide) and 5'-ATCC-TGTTATCTCTCTGACTGTCCG-3' (antisense oligonucleotide). The resulting 285 bp and 291 bp fragments of rat erbB-3 and erbB-4, respectively, were cloned into a Bluescript plasmid (Stratagene, La Jolla, CA). The two fragments encode amino acids 385 ± 480 and 305 ± 402 of the human homolog of ErbB-3 and ErbB-4, respectively. T3 and T7 RNA polymerases were used to generate [
35 S]-UTP-labeled sense and antisense transcripts, that were used as probes for in situ hybridization. Embedding, sectioning, post ®xation and hybridization of mouse embryos, were performed as described (Hogan et al., 1986) . Wistar rats were used for detailed analysis of expression in brain. Following perfusion of the animals with 2.5% paraformaldehyde, brains were removed and stored for 5 ± 10 days in 1% paraformaldehyde. Serial 7 ± 10 mm-thick coronal sections were prepared from frozen adult rat brains. Post-hybridization washing was performed for 30 min at 658C with 26SSC (16SSC is 150 mM NaCl, 15 mM sodium citrate, pH 7.0), 50% formamide and 0.1 M dithiothreitol. For autoradiography, Kodak NTB/2 emulsion was used and the slides were exposed for 1 ± 3 weeks. Finally, the sections were stained in hematoxylin-eosin stain and photographed in a Zeiss photomicroscope.
Cell culture
Primary cell cultures of embryonic rat brains (E17) were prepared by trypsinization as previously described (McCarthy and de Vellis, 1980) . The cultures were grown in Dulbecco's modi®ed Eagle's (DME) medium containing 10% fetal bovine serum (FBS), 2 mM glutamine, 50 u/ml penicillin and 50 mg/ml streptomycin. Astrocyte-and oligodendrocyte-enriched cultures were obtained from newborn rats using a previously described method (McCarthy and de Vellis, 1980) . Neuron-enriched cultures were prepared from E17 rat brains by using a modi®cation of the previously described procedure (Barde et al., 1980) . In brief, dissociated brain cells were suspended in F-12 medium containing 10% heat-inactivated horse serum and cultured for 4 h on a Falcon 10 cm dish. During this period, most of the non-neuronal cells adhered to the plastic surface and the¯oating cells were gently removed. T47D human mammary tumor cells and SK-BR3 cells were obtained from the American Type Culture Collection (Rockville, MD) and cultured in DME medium supplemented with 10% FBS (Hyclone, Logan, UT) in a humidi®ed incubator with 5% CO 2 at 378C. P19 cells were routinely propagated in minimal essential medium (aMEM) supplemented with 10% FBS. For dierentiation to the neural pathway, 4610 6 cells were suspended in 10 ml of medium containing 10% FBS and 1 mM retinoic acid (RA), and seeded onto a 10 cm bacteriological culture dish. Fresh medium with RA was replaced on every other day. After 4 days of RA treatment, aggregated cells were dissociated with trypsin and plated onto plates or coverslips precoated with poly-l-lysine. Treatment with recombinant proteins started immediately after plating and the factors re-added on each other day. Cytosine arabinoside (AraC) at a ®nal concentration of 10 mM was used in some experiments to inhibit cell division.
Immunocytochemistry
Cell cultures were ®xed for 10 min in ice-cold methanol and then washed twice with phosphate buered saline (PBS) containing 2% bovine serum (BS). Incubation with a monoclonal antibody to GAP-43 was carried out at room temperature for 60 min. Coverslips were washed 3 times with BS-containing PBS, followed by a 45 min-long incubation at room temperature with¯uoresceine-conjugated goat anti-mouse IgG and IgM (Jackson Immuno Research Laboratories, PA). The coverslips were subsequently washed as described above, and mounted in Mowiol. Immunolabeled cells were photographed using a Zeiss Universal microscope equipped with phase contrast and¯uorescence optics.
Lysate preparation and immunoblot
For analysis of total cell lysates, solubilization buer containing 50 mM HEPES pH 7.5, 150 mM NaCl, 10% glycerol, 1% Triton X-100, 1 mM EDTA, 1 mM EGTA, 1 mM MgCl 2 , 1 mM phenylmethylsulfonyl¯uoride, 500 mM Na 3 VO 4 , 5 mg/ml pepstatin A, 5 mg/ml leupeptin, and 5 mg/ ml aprotinin, was added to the monolayer on ice. Cells were scraped with a rubber policeman into 1 ml buer, transferred to microtubes, vortexed harshly and centrifuged (6006g, 10 min at 48C). Boiling gel sample buer was added to cell lysates, and proteins were resolved by SDS-polyacrylamide gel electrophoresis through 7.5% acrylamide gels, and electrophoretically transferred to a nitrocellulose membrane. Membranes were blocked for 2 h in TBST buer (0.02 Tris HCl pH 7.5, 0.15 M NaCl and 0.05% Tween 20) containing 1% milk, blotted with 1 mg/ ml primary antibodies for 2 h, followed by 0.5 mg/ml secondary antibody linked to horseradish peroxidase. Immunoreactive bands were detected with an enhanced chemiluminescence reagent (Amersham Corp).
Reverse-transcriptase PCR analysis
Total RNA was isolated from cultured cells by using an RNAzol kit. Synthesis of complementary DNA and PCR reactions were performed with the primers described above. The resulting 285 bp or 291 bp-long PCR products were tested by hybridization to the following internal oligonucleotide probes: 5'-GGGGCTTCTCATTGTTGATCAT-GAAG-3' (nucleotides 1376 ± 1401) and 5'-GCTCAGA-CTGTGGATTCCAG-3' (nucleotides 1066 ± 1085) speci®c to erbB-3 and erbB-4, respectively. The primers for ampli®cation of rat b-actin were as described (Jin et al., 1993) , and the resulting 310 bp-long PCR product was checked for speci®city by Southern blotting as described (Jin et al., 1993) . The ®rst strand of cDNA was synthesized at 378C in a reaction that contained reverse transcriptase (5 units, Promega), the sense primers (10 pmol each) and 2.5 mg RNA. PCR (25 cycles) was then performed with both primers (10 pmol each) under the following conditions: 1 min denaturation at 948C, 1 min annealing at 558C and 1.5 min elongation at 728C. Samples were resolved by electrophoresis through a 1% agarose gel and capillarytransferred with 206SSC to a Gene-Screen membrane (New England Nuclear). Synthetic probes were end-labeled and hybridized with the blots at 428C in the presence of 20% formamide. The blots were washed at 428C in a solution that contained 0.26SSC and 0.2% SDS. Washed membranes were exposed for 1 ± 2 days (erbB-4 and erbB-3 probes) or for 2 h (actin probe) at 7708C to AGFA Curix RP2 X-ray ®lms with intensifying screens.
Northern blot analysis
Total cellular RNA was isolated as described above. RNA aliquots (25 mg) were resolved by electrophoresis through a 1% agarose gel containing formaldehyde (6.5%), and capillary transferred with 106SSC to a Gene-Screen membrane (New England Nuclear). Probes were radioactively labeled with 32 P by random priming. Blots were hybridized for 8 h at 428C in 50% formamide, 66SSC, 16Denhart's solution, 50 mM Tris-HCl (pH 7.5), 1% SDS, 10% dextran sulfate and salmon sperm DNA (0.2 mg/ml). Blots were then washed for 1 h at 658C in 0.26SSC containing 0.2% SDS and exposed for 1 ± 2 weeks at 7708C to Kodak X-OMAT ®lms with two intensifying screens. The DNA probes used were a 1985 bp-long HindIII fragment of human erbB-4 (nucleotides 1028 ± 3013) and a 1671 bp-long HindIII fragment of human erbB-3 cDNA (nucleotides 559 ± 2230). The rat NDF probe was derived from a region shared by all isoforms (nucleotides 484 ± 973).
Preparation of whole cell extracts and gel retardation assays
Whole cell extracts were prepared from con¯uent 10 cm dishes of undierentiated or retinoic acid-dierentiated P19 cells. Cells were treated with NDF (100 ng/ml) for 30 min to 4 h as indicated and washed twice and scraped with phosphate buer saline (PBS) containing 2 mM sodium orthovandate, 10 mM sodium¯uoride, 0.5 mg/ml leupeptin and pepstatin, 2 mg/ml aprotinin and 0.5 mM benzamidine. Cells were resuspended in 0.4 ml buer A (10 mM HEPES-KOH, pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM DTT, 0.2 mM PMSF, 20 mM b-glycerophosphate, 10 mM p-nitrophenyl phosphate and 400 nM okadaic acid) and incubated on ice for 10 min, vortexed for 10 s and centrifuged for 10 s to pellet extracts. Pellets were resuspended in 50 ml cold buer C (20 mM HEPES-KOH, 25% glycerol, 420 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM DTT, 0.2 mM PMSF, 20 mM bglycerophosphate, 10 mM p-nitrophenyl phosphate, 400 nM okadaic acid) and incubated for 20 min at 48C. Cellular debris was pelleted by a 2 min centrifugation at 48C and the supernatant transferred to a fresh tube and snap frozen in liquid nitrogen. Protein concentration was determined by the Bradford assay. Extracts (10 mg) were incubated with 0.2 ng (50 000 c.p.m.) of end-labeled Egr-1 (5'-GATCGATTTCCCCGAAATG-3') oligonucleotide at room temperature for 20 min, together with 250 ng sheared salmon sperm DNA in binding buer to a ®nal concentration of 10 mM Tris-HCl, pH 7.5, 25 mM NaCl, 0.5 mM EDTA, 0.5 mM DTT, 2.5% glycerol and 0.025% non fat dry milk. Protein-DNA complexes were then reolved by electrophoresis on 4% non denaturing acrylamide gels run in 0.256Tris-borate-EDTA buer (TBE), dried and exposed to ®lm at 7708C with a screen.
